A group of pharmaceutical companies has issued a list of recommendations for improving the transparency and credibility of industry-supported clinical research. The recommendations include: Making all[…]
The California state legislature is currently considering a bill known as the Genetic Information Privacy Act. The bill includes very specific requirements for informed consent to[…]
The CDC has posted the latest Summary of Notifiable Diseases, which contains data for the year 2010. According to the CDC, “A notifiable disease is one[…]
Osiris Therapeutics’s drug Prochymal (remestemcel-L), for acute graft-versus host disease (GvHD), has been approved for marketing by regulators in Canada. The “drug” is approved for suppressing the[…]